Insider: Onyia Jude Chief Scientific Officer - NEUROCRINE BIOSCIENCES INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 18,289 | 0 | 18,289 |
| Value | $2,576,737.21 | $0.00 | $2,576,737.21 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 07/09/2025 | DDS | 59,819 | Direct | COM | $130.46 | $7,803,687.65 | 18,289 |
| 07/02/2025 | DDS | 20,362 | Direct | COM | $130.13 | $2,649,737.60 | 18,289 |
| 02/13/2025 | DDS | 1,432 | Direct | COM | $116.83 | $167,305.57 | 16,846 |
| 02/13/2025 | DDS | 1,447 | Direct | COM | $116.75 | $168,933.05 | 18,089 |
| 01/31/2025 | DDS | 126 | Direct | COM | $152.97 | $19,273.98 | 15,561 |
| 11/29/2024 | DDS | 2,331 | Direct | COM | $126.29 | $294,372.67 | 15,449 |
| 02/13/2024 | DDS | 1,432 | Direct | COM | $132.94 | $190,371.08 | 13,128 |
| 01/31/2024 | DDS | 126 | Direct | COM | $141.94 | $17,884.44 | 11,843 |
| 11/29/2023 | DDS | 2,331 | Direct | COM | $113.57 | $264,732.84 | 11,732 |
| 08/21/2023 | DDS | 3,198 | Direct | COM | $107.37 | $343,367.98 | 9,638 |
| 02/07/2023 | DDS | 4,508 | Direct | COM | $102.30 | $461,166.15 | 6,525 |
| 01/31/2023 | DDS | 126 | Direct | COM | $108.48 | $13,668.48 | 2,477 |
| 11/29/2022 | DDS | 2,331 | Direct | COM | $121.90 | $284,160.09 | 2,366 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research